CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE3978.40137.65 (+3.58 %)
PREV CLOSE () 3840.75
OPEN PRICE () 3855.00
BID PRICE (QTY) 3978.35 (4)
OFFER PRICE (QTY) 3982.35 (11)
VOLUME 19243
TODAY'S LOW / HIGH ()3840.75 4018.00
52 WK LOW / HIGH ()3050.15 4072.35
NSE3970.00126.2 (+3.28 %)
PREV CLOSE() 3843.80
OPEN PRICE () 3850.00
BID PRICE (QTY) 3969.85 (1)
OFFER PRICE (QTY) 3970.00 (147)
VOLUME 634746
TODAY'S LOW / HIGH() 3836.05 4016.95
52 WK LOW / HIGH ()3051 4074.4
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1990

Management Info :

Ramesh BV Nimmagadda - Chairman Murali K Divi - Managing Director

Registered Office :

Address : 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone : 040 66966300

Website : www.divislabs.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
26Apr Divi's Laboratories surges on planning
Divi's Laboratories is currently trading at Rs. 3988.50, up by 147.75 po..
25Apr Divi's Laboratories planning for capac
Divi's Laboratories is in the process of entering into a long-term suppl..
25Apr Divi’s Laboratories informs about disc
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obliga..
11Apr Divi's Laboratories informs about cert
Divi's Laboratories has informed that it enclosed certificate dated Apri..
30Mar Divi’s Laboratories informs about clos
Pursuant to the Company’s Code of Conduct for Prevention of Insider Trad..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit358018081.5
Gross Profit 4900 23541
Operating Profit 585026966.9
Net Sales 1808076253
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 25922.40 (0.77%)
M.Cap ( in Cr)
55141.94
Sanofi India (BSE)
 8287.60 (1.88%)
M.Cap ( in Cr)
19090.08
Astrazeneca Pharma I (BSE)
 5430.95 (2.47%)
M.Cap ( in Cr)
13583.38
Dr. Reddy's Lab (BSE)
 6280.95 (1.03%)
M.Cap ( in Cr)
104971.23
Glaxosmithkline Phar (BSE)
 2121.35 (2.71%)
M.Cap ( in Cr)
35953.04
Shareholding Pattern
PROMOTERS 51.92%
MUTUAL FUNDS/UTI 14.28%
NON-INSTITUTION 11.19%
FI/BANKS/INSURANCE 7.24%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX74164.39-175.05 (-0.24%)
NIFTY22531.90-38.45 (-0.17%)
Dow Jones 38085.80-375.12 (-0.98%)
Nasdaq 15611.76-100.99 (-0.64%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI